P1-385 A head study of donepezil, rivastigmine, and galantamine for the treatment of Alzheimer's disease: safety, tolerability, clinical and caregiver impressions after 9 months of treatment

✍ Scribed by Joshua R. Shua-Haim; Mark D. Pass; Suhas Patel; Sameer Patel; Paul Lee; Pritesh Patel; Juanita Smith

• Book ID: 117413258
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 155 KB
• Volume: 25
• Category: Article
• ISSN: 0197-4580
• DOI: 10.1016/s0197-4580(04)80697-3